AAMP Spring 2022

Quiz Questions: Chronic Neurological Disorders

Attendee Guidance

  • If you attended all 3 days of CME lectures, either “in-person” or “live stream”, you are not required to complete the quiz.
  • If you partially attended during the 3 days, or missed all 3 days, in addition to completion of the on-line Evaluation Form, you are also required to complete the multiple-choice questions for ONLY those CME lectures that you missed, to be eligible for CME accreditation.
  • Once you have watched those lectures that you missed live, please answer the questions pertaining to the specific lecture. 66% or over per section need to be answered correctly to pass.
  • Once completed, simply press Submit
  • From receipt, processing and issuing your certificate will take 7-10 days. We will communicate with you should we have any queries.
  • Any questions, please call Jeremy Phillips, AAMP Educational Credit Coordinator at 954.540.1286
  • Deadline for submissions: August 22nd, 2022

Friday 8:00-9:00
Dr. Anderson

“Neurochemistry - 1 Neurohormonal and Metabolic Factors in Neurology”

The blood brain barrier is commonly damaged in neurological inflammation, infection, trauma, and autoimmunity:
“Neurosteroids” discussed include:
Histamine has _________ main elimination pathways:

Friday 9:00-10:00
Dr. Heisig

Section #1: Identifying the issues in concussion/PCS (The “5 buckets”)

TBI is thought to be exceedingly rare:
Persistent Concussion Syndrome is persistence of symptoms greater than ____ days in adults and ___ in children:

Friday 10:45-11:45
Dr. Anderson

Neurochemistry - 2 Neurotransmitters

An apparent neurotransmitter imbalance may be affected by:
Non-linear dosing of cofactors can involve:
Neurosteroids, GABA, Glycine are examples of:

Friday 11:45-12:30
Dr. Anderson

“Neurochemistry - 3 Neurological Genomic Factors”

A SNP will always manifest as a pathological effector:
A SNP may be activated by an epigenetic stressor:
Strategies for reducing the effects of active SNP's may include:

Friday 2:15-3:45
Dr. Zelfand

“The Science of Psychedelics - How psilocybin, LSD, and other "classic" psychedelics work on the brain”

Psychadelics as described have only one mechanism of action in the nervous system:
Psychadelics discussed include:

Friday 5:00-6:00
Dr. Anderson

“Specific Therapeutics in Neurological Healing”

Modlaities discussed included:
One photodynamic therapy discussed was:
Pediatric neurological recovery using HBOT was included:

Saturday 8:15-9:15
Dr. Sharlin

“Neurological Autoimmunity; Multiple Sclerosis Considerations Part-1”

Regarding using MRI in place of neurological work-up it was stated:
The following statement was made in regard to MS: “Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease of the central nervous system. It is characterized by central nervous system (CNS) inflammation, oligodendrocyte loss, demyelination, and axonal degeneration. What is less clear is whether the autoimmunity of MS is primary or secondary?”

Saturday 9:15-9:45
Dr. Anderson

“Integrative Considerations In Neurological Autoimmunity”

The following is a true characterization in regard to this presentation:
The talk focused on an integrative approach:
The talk recommended taking the process very slowly in an ALS case:

Saturday 10:30-11:30
Dr. Sharlin

“Neurological Autoimmunity; Multiple Sclerosis Considerations Part-2”

This presentation included an overview of the standard neurology approach:
This presentaion also included discussion of:

Saturday 11:30-12:30
Dr. Sharlin

“Neurological Autoimmunity; Multiple Sclerosis Considerations Part-3”

As mentioned in this presentation:
Disease modifying therapies include:

Saturday 2:15-3:15
Dr. VanGaver

“Addiction: Opiate Addiction”

Oxycontin can become a drug of addiction:
Addiction treatment can be:

Saturday 4:30-5:30
Dr. VanGaver

“Addiction: Benzodiazepine Addiction”

Addiction to substances such as lorazepam are:
The MAJORITY of benzodiazepine addiction cases are due to non prescribed / illegally obtained drugs:

Sunday 8:15-9:45
Dr. Zelfand

“Microdosing - What we know (and don't) about taking miniscule doses of psilocybin and LSD on a regular basis”

Microdosing is often ______ the dose used "recreationally":
Motivations for microdosing include depression and anxiety:

Sunday 9:45-10:45
Dr. VanGaver

“Addiction: Alcohol Addiction”

Alcohol addiction:
A major effect of alcohol is in the:

Sunday 11:30-12:30
Dr. VanGaver

“Addiction: Case Studies”

The cases indicated that:
Approaching the treatment of addiction is best:

Sunday 1:45-2:45
Dr. Heisig

“Section #2: Management of the issues in concussion/PCS"

Evidence based approach included:
The "buckets" described included:

Sunday 2:45-3:45
Dr. Heisig

“Section #3: Considerations for athletes & RTP”

The approach for athletes with brain trauma:
Concussion baseline testing is used for the return-to-play decision:

Sunday 3:45-4:30
Dr. Anderson

“Case Study: Synergistic Therapies in the Traumatized Brain”

In this case, Dr. Anderson used photodynamic therapies:
The use of combined therapies appeared to:
HBOT and IV + Oral ReDox support were main interventions in this case:
This field is for validation purposes and should be left unchanged.